Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-13
DOI
10.1038/s41419-021-04367-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
- (2021) Umberto Malapelle et al. EUROPEAN JOURNAL OF CANCER
- Broadening horizons: the role of ferroptosis in cancer
- (2021) Xin Chen et al. Nature Reviews Clinical Oncology
- Quiescin Sulfhydryl Oxidase 1 Promotes Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving EGFR Endosomal Trafficking and Inhibiting NRF2 Activation
- (2021) Jialei Sun et al. Redox Biology
- HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer
- (2021) Said A. Khelwatty et al. Cancers
- Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin
- (2021) Changshun Yang et al. Aging-US
- Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis
- (2021) Junfeng Huang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer
- (2021) Bing Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy
- (2021) A.L. Noordhof et al. LUNG CANCER
- CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers
- (2021) Hae Rim Jung et al. ONCOGENE
- Integrated approaches for precision oncology in colorectal cancer: The more you know, the better
- (2021) Pietro Andrei et al. SEMINARS IN CANCER BIOLOGY
- Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes
- (2021) Barbara Manzanares-Martin et al. Journal for ImmunoTherapy of Cancer
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy
- (2020) Shengdi Guo et al. Frontiers in Pharmacology
- MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling
- (2020) Ying Han et al. Advanced Science
- Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
- (2020) Annalisa Lorenzato et al. Cancers
- Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
- (2020) Jian-Shu Lou et al. PHYTOMEDICINE
- Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status
- (2020) Benny Vittrup Jensen et al. INTERNATIONAL JOURNAL OF CANCER
- NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
- (2019) Matthew Dodson et al. Redox Biology
- Ferroptosis is a type of autophagy-dependent cell death
- (2019) Borong Zhou et al. SEMINARS IN CANCER BIOLOGY
- Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
- (2019) Ilya G. Serebriiskii et al. Nature Communications
- Low-Concentration PTX And RSL3 Inhibits Tumor Cell Growth Synergistically By Inducing Ferroptosis In Mutant p53 Hypopharyngeal Squamous Carcinoma
- (2019) Jing Ye et al. Cancer Management and Research
- The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
- (2019) Karmele Valencia et al. JOURNAL OF CLINICAL INVESTIGATION
- The Development of the Concept of Ferroptosis
- (2018) Tal Hirschhorn et al. FREE RADICAL BIOLOGY AND MEDICINE
- Lonchocarpine Increases Nrf2/ARE-Mediated Antioxidant Enzyme Expression by Modulating AMPK and MAPK Signaling in Brain Astrocytes
- (2016) Yeon-Hui Jeong et al. Biomolecules & Therapeutics
- FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
- (2016) L Marzi et al. BRITISH JOURNAL OF CANCER
- Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis
- (2016) Xiaofang Sun et al. HEPATOLOGY
- Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
- (2016) Yijun Tian et al. Journal of Hematology & Oncology
- Cysteine Sulfenylation Directs IRE-1 to Activate the SKN-1/Nrf2 Antioxidant Response
- (2016) John M. Hourihan et al. MOLECULAR CELL
- Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab
- (2015) S. Napolitano et al. CLINICAL CANCER RESEARCH
- MicroRNA-7expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity viaEGFRregulation
- (2014) Toshinaga Suto et al. CARCINOGENESIS
- Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
- (2014) T. Troiani et al. CLINICAL CANCER RESEARCH
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab
- (2011) R. C. Wadlow et al. ONCOLOGIST
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells
- (2008) Wan Seok Yang et al. CHEMISTRY & BIOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now